Abstract
The long-term goal of our study is to explore how Epstein-Barr virus (EBV) associates with the pathogenesis of gastric carcinoma. The first goal is to establish EBV-positive epithelial cell lines from EBV-infected gastric carcinoma tissues and to characterize the cell lines and EBV infection in the cells. EBV, a ubiquitous human herpesvirus with oncogenic potential, is predominantly associated with the infection of two target tissues in vivo: (1) B lymphocytes, where the infection is largely nonproductive, and (2) the epithelium, in which virus replication occurs (Rickinson and Kieff 1996). Both target tissues are susceptible to EBV-associated malignant change, leading to tumors of B-cell origin, such as Burkitt’s lym-phoma, or of epithelial-cell origin, such as nasopharyngeal carcinoma (NPC) (Pathmanathan et al. 1995). Recently, EBV has also emerged as an etiologic agent implicated in gastric carcinoma (Min et al. 1991; Shibata et al. 1991; Shibata and Weiss 1992; Tokunaga et al. 1993a,b; Fukayama et al. 1994; Imai et al. 1994; Ohfuji et al. 1996; Iwasaki et al. 1998). EBV has been found in most cases of rare gastric lymphoepithelioma-like carcinomas (Min et al. 1991; Shibata et al. 1991; Ohfuji et al. 1996) and a small but significant proportion of common gastric adenocarcinomas (Shibata and Weiss 1992; Tokunaga et al. 1993a,b). EBV infection was found in approximately 7% of Japanese gastric carcinomas (Tokunaga et al. 1993a,b; Fukayama et al. 1994; Imai et al. 1994). The world distribution of gastric carcinomas with EBV infection is shown from 4% to 18% of total gastric carcinoma in different countries (Tashiro et al. 1998)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA (1995) Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 69:7001–7005
Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851
Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whiteney BM, Lee JCK (1999) Nasopharyngeal carcinoma cell line (C666-l) consistently harbouring Epstein-Barr virus. Int J Cancer 83:121–126
Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A (1986) Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. Embo J 5:3243–3249
Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085–4089
Croen KD (1993) Evidence for antiviral effect of nitric oxide: Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91:2446–2452
Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K (1994) Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71:73–81
Gao X, Tajima M, Sairenji T (1999) Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. Virology 258:375–381
Gilad E, Zingarelli B, Salzman AL, Szabo C (1997) Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol 29:2585–2597
Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP (1989) Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86:9524–9528
Harris N, Buller RM, Karupiah G (1995) Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 69:910–915
zur Hausen H, O’Neill FJ, Freese UK, Hecker E (1978) Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272:373–375
Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T (2000) Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes and Infection 2:115–120
Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131–9135
Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371–4378
Iwasaki Y, Chong JM, Hayashi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M (1998) Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321–8326
Kanamori M, Tajima M, Satoh Y, Hoshikawa Y, Miyazawa Y, Okinaga K, Kurata T, Sairenji T (2000) Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji. Virus Genes 20:117–125
Katano H, Morishita Y, Cui LX, Watanabe T, Hirai K, Mori S (1996) Expression of latent membrane protein 1 in clinically isolated cases and animal models of AIDS-associated non-Hodgkin’s lymphomas. Pathol Int 46:568–574
Kawanishi M (1995) Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV. Intervirology 38:206–213
Klein G (1998) EBV and B cell lymphomas. In: Medveczky PG, Friedman H, Bendinelli M (eds) Herpesvirus and immunity. Plenum Press, New York and London
Kunimoto M, Tamura S, Tabata T, Yoshie O (1992) One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol 73:455–461
Luka J, Kallin B, Klein G (1979) Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231
MacPherson I, Montagnier L (1964) Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23:291–297
Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137–1146
Min KW, Holmquist S, Peiper SC, O’Leary TJ (1991) Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach: Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 96: 219–227
Murakami M, Hoshikawa Y, Satoh Y, Ito H, Tajima M, Okinaga K, Miyazawa Y, Kurata T, Sairenji T (2000) Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse. Virology 277:20–26
Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051–3064
Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K (1999) Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 73:1286–1292
Ohfuji S, Osaki M, Tsujitani S, Ikeguchi M, Sairenji T, Ito H (1996) Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int J Cancer 68:710–715
Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698
Pope M, Marsden PA, Cole E, Sloan S, Fung LS, Ning Q, Ding JW, Leibowiz JL, Phillips MJ, Levey GA (1998) Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J Virol 72:7084–7090
Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889
Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al. (eds) Fields Virology, 3rd edn. Raven Press, New York
Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147–158
Sairenji T, Hinuma Y (1980) Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int J Cancer 26:337–342
Sekiguchi M, Suzuki T (1994) Gastric tumor cell lines. In: Hay RJ, Park J-G, Gazdar AF (eds) Atlas of human tumor cell lines. Academic Press, London
Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469–474
Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769–774
Shimizu N, Tanabe Tochikura A, Kuroiwa Y, Takada K (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt’s lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069–6073
Tajima M, Komuro M, Okinaga K (1998) Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J Cancer Res 89:262–268
Takada K, Shimizu N, Sakuma S, Ono Y (1986) Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57:1016–1022
Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T, Sairenji T (1998) Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Virology 247:152–159
Takimoto T, Ogura H, Sato H, Umeda R, Hatano M (1985) Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). J Natl Cancer Inst 74:57–60
Tashiro Y, Arikawa J, Itoh T, Tokunaga M (1998) Clinico-pathological findings of Epstein-Barr virus-related gastric cancer. In: Osato T, Takada K, Tokunaga M (eds) Epstein-Barr virus and human cancer. Monograph on cancer research No. 45, Japan Scientific Society Press, Karger, Basel Freiburg Paris London New York New Delhi Bangkok Singapore Tokyo Sydney
Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E (1993a) Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250–1254
Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, Kaneko K, Naoe S, Ito M,Okamura A, Shimada A, Sato E, Land CE (1993b) Epstein-Barr virus related gastric cancer in Japan:a molecular patho-epidemiological study. Acta Pathol Jpn 43:574–581
Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, Glaser R (1990) Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 45:83–89
Yoshiyama H, Imai S, Shimizu N, Takada K (1997) Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD2l. J Virol 71:5688–5691
Zalani S, Holley Guthrie E, Kenney S (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA 93:9194–9199
Zhang HY, Yao K, Zhu HC, Glaser R (1990) Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Int J Cancer 46:944–949
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sairenji, T. et al. (2001). Characterization of EBV-Infected Epithelial Cell Lines from Gastric Cancer-Bearing Tissues. In: Takada, K. (eds) Epstein-Barr Virus and Human Cancer. Current Topics in Microbiology and Immunology, vol 258. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56515-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-56515-1_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62568-8
Online ISBN: 978-3-642-56515-1
eBook Packages: Springer Book Archive